Log in to your Inderes Free account to see all free content on this page.
Lipidor
0.048 SEK -1.65%2 investors are following this company
Lipidor is a pharmaceutical company. The company works with research and development in the preclinical and clinical phases. The largest business is established in the development of pharmaceuticals that are further used for the treatment of various skin diseases. Examples of diseases that are treated include psoriasis, various skin infections, and atopic dermatitis. The head office is located in Solna.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
LIPI
Daily low / high price
0.047 / 0.049
SEK
Market cap
38.88M SEK
Turnover
101.87K SEK
Volume
2.1M
Financial calendar
Interim report
28.08.2024
Interim report
20.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Cerbios-Pharma SA | 13.7 % | 13.7 % |
Aurena Laboratories AB | 5.6 % | 5.6 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Lipidor's rights issue and share capital reduction are registered – conversion of BTU into shares and warrants
Lipidor announces final outcome in the rights issue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio